Tracking growth in high-risk choroidal nevi revealed key genetic shifts and low metastatic risk, supporting timely intervention to prevent progression to aggressive UM.
The post Monitoring Tumor Growth to Predict UM Progression first appeared on Physician’s Weekly.
